Treatment of Malignant Pelvic Tumors by Extracorporeal Perfusion with Chemotherapeutic Agents
- 19 November 1959
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 261 (21), 1037-1045
- https://doi.org/10.1056/nejm195911192612101
Abstract
AN important limitation to intravenous systemic use of nitrogen mustard and allied compounds has been the toxicity of the drugs to the normal tissues of the gastrointestinal tract and hematopoietic system.1 Doses within the limits of systemic tolerance are often without tumorocidal effect, and larger doses may cause systemic toxicity hazardous to life. Direct intra-arterial administration of nitrogen mustard produces high local tumorocidal levels but does not entirely eliminate systemic toxicity2 and is frequently associated with severe local reaction and vascular thrombosis.3 , 4 By isolating the circulation of a region bearing a tumor and perfusing it by a method utilizing an . . .Keywords
This publication has 10 references indexed in Scilit:
- Treatment of Kaposi's Sarcoma of the Lower Extremity by Extracorporeal Perfusion with Chemotherapeutic AgentsNew England Journal of Medicine, 1959
- Hemisulfur Mustard in the Palliation of Patients with Metastatic Ovarian CarcinomaObstetrics & Gynecology, 1959
- TREATMENT OF MELANOMA BY ISOLATION-PERFUSION TECHNIQUEJAMA, 1959
- KAPOSI'S SARCOMA TREATED WITH NITROGEN MUSTARDThe Lancet, 1959
- Chemotherapy of CancerAnnals of Surgery, 1958
- INTRA-ARTERIAL NITROGEN MUSTARD IN THE TREATMENT OF PELVIC CANCERAnnals of Internal Medicine, 1958
- II. Clinical ApplicationThe British Journal of Radiology, 1957
- I. Radiobiological ConsiderationsThe British Journal of Radiology, 1957
- FRACTIONATED INTRA-ARTERIAL CANCER. CHEMOTHERAPY WITH METHYL BIS AMINE HYDROCHLORIDE; A PRELIMINARY REPORTAnnals of Surgery, 1950
- The Nitrogen Mustards: Clinical UseRadiology, 1948